HUS1600039I1 - Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával - Google Patents

Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával

Info

Publication number
HUS1600039I1
HUS1600039I1 HUS1600039C HUS1600039C HUS1600039I1 HU S1600039 I1 HUS1600039 I1 HU S1600039I1 HU S1600039 C HUS1600039 C HU S1600039C HU S1600039 C HUS1600039 C HU S1600039C HU S1600039 I1 HUS1600039 I1 HU S1600039I1
Authority
HU
Hungary
Prior art keywords
oritavancin
treatment
methods
single doses
doses
Prior art date
Application number
HUS1600039C
Other languages
English (en)
Original Assignee
The Medicines Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41722337&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUS1600039(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The Medicines Co filed Critical The Medicines Co
Publication of HUS1600039I1 publication Critical patent/HUS1600039I1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
HUS1600039C 2008-08-30 2016-10-06 Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával HUS1600039I1 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9331408P 2008-08-30 2008-08-30
US9349708P 2008-09-02 2008-09-02
EP09810708.9A EP2337575B1 (en) 2008-08-30 2009-08-29 Methods of treatment using single doses of oritavancin

Publications (1)

Publication Number Publication Date
HUS1600039I1 true HUS1600039I1 (hu) 2016-11-28

Family

ID=41722337

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE09810708A HUE027373T2 (hu) 2008-08-30 2009-08-29 Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával
HUS1600039C HUS1600039I1 (hu) 2008-08-30 2016-10-06 Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HUE09810708A HUE027373T2 (hu) 2008-08-30 2009-08-29 Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával

Country Status (16)

Country Link
US (2) US8420592B2 (hu)
EP (2) EP3006038B1 (hu)
JP (1) JP5782615B2 (hu)
CN (2) CN102215858A (hu)
AU (1) AU2009285564B2 (hu)
CA (1) CA2736860C (hu)
DK (1) DK2337575T3 (hu)
EA (1) EA020490B1 (hu)
ES (1) ES2570401T3 (hu)
HU (2) HUE027373T2 (hu)
MX (1) MX2011002249A (hu)
NL (1) NL300834I2 (hu)
NO (1) NO2016019I2 (hu)
NZ (1) NZ591525A (hu)
PL (1) PL2337575T3 (hu)
WO (1) WO2010025438A2 (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8420592B2 (en) * 2008-08-30 2013-04-16 The Medicines Company Methods of treatment using single doses of oritavancin
EP2424559B1 (en) * 2009-04-28 2024-04-03 Melinta Therapeutics, LLC Methods of treating bacterial infections using oritavancin
US20150246024A1 (en) * 2012-08-20 2015-09-03 The University Of Chicago Methods and compositions for inhibiting gram positive bacteria
WO2014176068A2 (en) * 2013-04-22 2014-10-30 The Medicines Company Treatment and prevention of bacterial skin infections using oritavancin
PL3038616T3 (pl) * 2013-08-26 2023-08-07 Melinta Therapeutics, Inc. Metody leczenia bakteriemii i zapalenia kości i szpiku z zastosowaniem orytawancyny
WO2015031579A2 (en) * 2013-08-28 2015-03-05 The Medicines Company Methods for treating bacterial infections using oritavancin and polymyxins
WO2015192031A1 (en) * 2014-06-12 2015-12-17 Cem-102 Pharmaceuticals, Inc. Compositions and methods for treating bone and joint infections
AU2015289602B2 (en) 2014-07-17 2020-06-25 Abbvie Inc. High purity oritavancin and method of producing same
BR112018016715A2 (pt) 2016-02-18 2019-02-19 Melinta Therapeutics, Inc. ?formulações de oritavancina?
WO2017179003A1 (en) * 2016-04-15 2017-10-19 Lupin Limited Topical compositions for ophthalmic and otic use
CN108409837B (zh) * 2018-03-06 2021-09-24 上海来益生物药物研究开发中心有限责任公司 一组具有抗耐药性细菌活性的糖肽类化合物、其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840684A (en) 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5994297A (en) 1997-08-22 1999-11-30 Eli Lilly And Company Therapy for Staphylococcus aureus
HUP0200940A3 (en) 1999-05-03 2002-10-28 Lilly Co Eli Use of glycopeptide antibiotic for treatment of streptococcus pneumoniae infections and pharmaceutical compositions containing them
AU2001259306A1 (en) 2000-05-02 2001-11-12 Advanced Medicine, Inc. Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
US20030176327A1 (en) * 2001-10-25 2003-09-18 Cassell Gail Houston Antibiotics for treating biohazardous bacterial agents
CN1662643A (zh) * 2002-05-28 2005-08-31 贝克顿·迪金森公司 人腺泡细胞的扩增和转分化
AU2003274927A1 (en) * 2002-08-23 2004-03-11 Genome Therapeutics Corporation Methods and reagents for preventing bacteremias
US20040127403A1 (en) * 2002-09-06 2004-07-01 Francesco Parenti Methods for treating and preventing Gram-positive bacteremias
US20070249577A1 (en) * 2005-05-10 2007-10-25 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
EP2068890B1 (en) 2006-09-25 2014-01-08 The Medicines Company Use of oritavancin for prevention and treatment of anthrax
US8420592B2 (en) * 2008-08-30 2013-04-16 The Medicines Company Methods of treatment using single doses of oritavancin
EP2424559B1 (en) * 2009-04-28 2024-04-03 Melinta Therapeutics, LLC Methods of treating bacterial infections using oritavancin
WO2015031579A2 (en) * 2013-08-28 2015-03-05 The Medicines Company Methods for treating bacterial infections using oritavancin and polymyxins

Also Published As

Publication number Publication date
CA2736860A1 (en) 2010-03-04
US8420592B2 (en) 2013-04-16
WO2010025438A9 (en) 2010-05-14
MX2011002249A (es) 2011-06-24
EP2337575B1 (en) 2016-04-13
HUE027373T2 (hu) 2016-09-28
NO2016019I2 (no) 2019-01-25
NZ591525A (en) 2014-03-28
EP3006038B1 (en) 2024-07-03
JP2012501349A (ja) 2012-01-19
AU2009285564A1 (en) 2010-03-04
US20110201546A1 (en) 2011-08-18
AU2009285564B2 (en) 2014-05-22
EP3006038A1 (en) 2016-04-13
EP2337575A4 (en) 2012-10-17
CN102215858A (zh) 2011-10-12
NL300834I2 (hu) 2016-11-16
DK2337575T3 (en) 2016-05-23
US20130172237A1 (en) 2013-07-04
ES2570401T3 (es) 2016-05-18
EP2337575A1 (en) 2011-06-29
JP5782615B2 (ja) 2015-09-24
CN106620649A (zh) 2017-05-10
EA201100413A1 (ru) 2012-01-30
CA2736860C (en) 2020-04-28
EA020490B1 (ru) 2014-11-28
PL2337575T3 (pl) 2016-09-30
NO2016019I1 (no) 2016-10-11
WO2010025438A2 (en) 2010-03-04

Similar Documents

Publication Publication Date Title
HUS1600039I1 (hu) Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával
HUS1600057I1 (hu) Kezelési eljárások ammónia-megkötõ hatóanyag alkalmazásával
IL208354A0 (en) Methods of treatment
ZA201106730B (en) Methods of treatment using combination therapy
HK1156631A1 (en) Novel compounds and methods for therapy
HRP20181877T1 (hr) Postupci za liječenje lijekovima koji uklanjaju amonijak
EP2350641A4 (en) Methods of Treatment
ZA201000225B (en) Treatment of depression
EP2424529A4 (en) NEW THERAPEUTIC TREATMENTS WITH CENTHAQUIN
EP2164494A4 (en) Methods of Treatment
GB0723100D0 (en) Treatment of HFnEF
EP2424539A4 (en) PROCESS FOR TREATING DEPRESSION
EP2440238A4 (en) Methods of Treatment
GB0809816D0 (en) Treatment of ringworm
SI2330892T1 (sl) Postopki zdravljenja z uporabo zdravil, ki odstranjujejo amoniak
GB0700969D0 (en) Methods of treatment
AU2008902372A0 (en) Methods of treatment
GB2465211B (en) Treatment Solution
GB0816217D0 (en) Treatment of hepatitis C
GB0823435D0 (en) Method of treatment
AU2009905173A0 (en) Methods of treatment
AU2009904460A0 (en) Methods of treatment
AU2009902633A0 (en) Methods of treatment
GB0804468D0 (en) Treatment of influenza